prednisolone has been researched along with Cardiotoxicity in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, B | 1 |
| Yu, Y | 1 |
| Zhang, Y | 1 |
| Hao, X | 1 |
| Zhao, H | 1 |
| Yang, S | 1 |
| Sun, Q | 1 |
| Wang, Y | 1 |
1 other study available for prednisolone and Cardiotoxicity
| Article | Year |
|---|---|
Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cyclophosphamide; Do | 2020 |